Laboratory procedures and precautions for samples collected from patients with suspected viral haemorrhagic fevers

The purpose of these guidelines is to allow the necessary on-site testing for other possible causes of the illness, and other testing required for the immediate and ongoing management of the patient.

Page last updated: 13 November 2014

Prepared by the Public Health Laboratory Network
Published by Australian Government Department of Health
October 2014

Synopsis

The viral haemorrhagic fevers (VHFs) group of diseases comprises Lassa fever (LF), Congo-Crimean haemorrhagic fever, Ebola and Marburg virus infections.

The Public Health Laboratory Network undertook to produce a set of guidelines Laboratory procedures and precautions for samples collected from patients with suspected viral haemorrhagic fevers that allows processing of viral haemorrhagic fever (VHF) samples in laboratories with Biosafety level 3 facilities or, if absolutely necessary, in those with only biosafety level 2 facilities. The purpose of the guidelines is to allow the necessary on-site testing for other possible causes of the illness, and other testing required for the immediate and ongoing management of the patient.

Please note:
The full document was initially written and published in March 2002.
Part A has been amended and republished in October 2014
Part B has been amended and republished in October 2014

The guidelines consist of:

Part A

and

Part B

If you are unable to download any of these documents please Email: OHP Webmaster